Grey Market: India is ageing faster than its care systems can keep up. A new wave of startups is trying to bridge that gap

A growing number of cases of memory loss and dementia are highlighting India’s lack of early intervention and eldercare support, as the country faces a rapid rise in its ageing population. India has nearly 100 million people above 60, a number expected to exceed 300 million by 2050.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/nw4mtSz
via IFTTT

Read More

Work on reducing import dependence for raw materials: Commerce Secretary Rajesh Agrawal to pharma industry

Commerce Secretary Rajesh Agrawal has called on India's pharmaceutical sector to boost domestic production and reduce reliance on imported raw materials. He emphasized diversifying export markets to navigate global uncertainties. Agrawal stressed the need for India to become a global hub for quality and cost-effective medicines. The focus is on innovation and moving towards a value-driven industry.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/b1sWjxl
via IFTTT

Read More

Lalitpur Pharma Park gets export push as UPSIDA, JNPA sign pact

Uttar Pradesh State Industrial Development Authority and Jawaharlal Nehru Port Authority have partnered. This agreement aims to make the Lalitpur Pharma Park a global export hub. The collaboration will connect northern India's industrial regions to international markets. This strategic move will boost pharmaceutical exports and imports. It will also enhance logistics for manufacturers.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/nNlDrgw
via IFTTT

Read More

India’s pharma exports stay resilient amid global headwinds, near $29 billion mark

Indian pharmaceutical exports are performing strongly. Shipments neared $29 billion by February this financial year. This growth continues despite global market volatility. Formulations, biologicals, vaccines, and Ayush products are leading the surge. The sector is poised for significant expansion by 2030. India remains a vital global supplier of affordable medicines.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/G42yv0f
via IFTTT

Read More

Govt orders safety review of popular weight-loss drugs amid rising demand

Indian authorities are increasing vigilance on popular weight loss drugs. The Indian Pharmacopoeia Commission will now compile reports on adverse events. This move aims to ensure safety and timely action. Generic versions of these drugs are expected to become widely available soon. Regulatory bodies are also cracking down on misleading advertisements for prescription medicines.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/zVMvPFC
via IFTTT

Read More

Why healthcare access still depends on affordability in India, and how universal insurance may change that

India's healthcare system faces affordability challenges despite infrastructure advancements, with out-of-pocket spending causing financial stress. Universal health insurance and digital integration are crucial for equitable access, preventive care, and a patient-focused model. Expanding infrastructure beyond metros and adopting holistic approaches are key to reducing inequality and improving outcomes.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/UlEN6cY
via IFTTT

Read More

India's 'Mounjaro brides': Weight-loss injections become part of pre-wedding preparation

With wedding season in full swing, Indian health clinics are rolling out specialized weight-loss packages that include popular drugs such as Mounjaro and Wegovy. This emerging trend underscores the immense societal pressure to achieve a perfect look in a short span of time.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/6JtLMfi
via IFTTT

Read More